Home / Nervous system / Buprenorphine
ATC N02AE01 · Analgesics
Buprenorphine shortage
As of 31 Oct 2026, Buprenorphine has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Austria), covering 8 products.
Countries4/5
Products8packs or presentations
Short since13 Mar 20242.6 years ago
Earliest return14 Nov 2026company estimate
No return date4products
Main reasonIncreased demand
Timeline
GermanyItalySpainAustria
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Buprenorphin-ratiopharm 70 Mikrogramm/h Transdermales Pflaster | ratiopharm GmbH | 13 Mar 2024 | 24 Nov 2026 | Increased demand Erhöhte Nachfrage |
| DE | Buprenorphin-ratiopharm 70 Mikrogramm/h Transdermales Pflaster | ratiopharm GmbH | 13 Mar 2024 | 24 Nov 2026 | Increased demand Erhöhte Nachfrage |
| DE | Buprenorphin-ratiopharm 70 Mikrogramm/h Transdermales Pflaster | ratiopharm GmbH | 13 Mar 2024 | 24 Nov 2026 | Increased demand Erhöhte Nachfrage |
| IT | DURLEVATEC | SANDOZ S.P.A. | 5 May 2026 | not given | Regulatory or licensing Problemi regolatori |
| ES | BUPRENORFINA STADA 35 MICROGRAMOS/HORA PARCHE TRANSDERMICO 96 HORAS EFG, 5 parches transdérmicos | Laboratorio Stada S.L. | 7 Jul 2026 | 14 Nov 2026 | Not stated |
| AT | Buprenorphin ratiopharm 10 Mikrogramm/h transdermales Pflaster, 2 Stück | Teva B.V. | 15 Jun 2026 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Buprenorphin ratiopharm 5 Mikrogramm/h transdermales Pflaster, 2 Stück | Teva B.V. | 15 Jun 2026 | not given | Distribution or logistics Verzögerung bei der Auslieferung |
| AT | Buprenorphin ratiopharm 20 Mikrogramm/h transdermales Pflaster, 2 Stück | Teva B.V. | 19 Oct 2026 | not given | Distribution or logistics Verzögerung bei der Auslieferung |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.